Precision BioSciences Announces Allowance of Third U.S. Patent Related to Engineered Meganucleases

Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S.

Precision BioSciences Announces Allowance of Second U.S. Patent for Engineered Meganucleases

Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S.

Mojang CEO on scaling up for two new projects

In this interview, the Minecraft developer's CEO talks about its tight community relationship, and how that effects everything from recruiting developers to working on its legal defense in the Scrolls legal case versus ZeniMax. "They say we're the first company in history to crowdsource a defense in court," Mojang CEO Carl Manneh tells Gamasutra. "We put out all the documents online and we got ...

Precision BioSciences Announces Allowance of Fourth U.S. Patent Related to Engineered Meganucleases

Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S.

NCR Earns TL 9000 Certification in Support of Its Telecom and Technology Business

NCR Corporation today announced that it has earned TL 9000 certification as part of its global continuous improvement and quality management initiatives. TL 9000 is an